#COPD FLUTTER DEVICE TRIAL#
The effects of T-PEP on ventilation lung scan in patients with bronchiectasis: Protocol for a randomized controlled trial Source: International Congress 2018 – New insights in the management of chronic respiratory failure Nasal vs oronasal interface during exercise under noninvasive ventilation in COPD: A randomized cross-over study Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Nasal high-flow therapy (NHFT) during exercise in patients with cystic fibrosis (CF): a randomized crossover trial Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care
The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis- A randomised controlled trial
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Source: International Congress 2017 – New insights in chronic respiratory failureĪzithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial. Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomesĭomiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatmentĮffectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study Source: ERJ Open Res, 5 (4) 00186-2019 10.1183/23120541.00186-2019Ī randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis 48, 406sĪ feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol Treatment was performed twice daily till patient get discharged.Related content which might interest you: Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques (ACBT) versus a new device Measurements of dependent variable 5 minutes after treatment were made. Patients were asked to cough and expectorate their sputum. In group C usual conventional treatment was given to the patient including breathing training (pursed lip breathing) for 15 minutes. Measurements of dependent variable 5 minutes after the treatment were done. This cycle was performed for 15 minutes per session. Now, patients exhale forcefully through the Flutter, as completely and as comfortable as possible. Again perform a 2 to 3 second breath-hold. Then patient was asked to breathe in slowly and as fully as comfortably possible, really fill the lungs with air. In group B patient was instructed to keep the flutter in an angle from floor so that maximum fluttering was felt. Measurements of dependent variable after 5 minutes of treatment were made same as before the treatment. The whole treatment was repeated for approximately 15 minutes. In group A after the measurement of variables patient follows ACBT consisted of 4-6 breathing control breaths, 3-4 thoracic expansion exercises, and the forced expiration technique including 4-6 breathing control breaths combined with 2-3 huffs. A pre-intervention and post intervention determination of the dependent variables PEFR, SpO2 and RR was done daily and recorded until the patient get discharge. Twice daily patients were treated in morning and evening till they got discharged. Subjects in group A treated with ACBT, subjects in group B treated with FLUTTER and subjects in group C were treated with general breathing exercises. Subject meeting the inclusion and exclusion criteria randomly assigned in the groups and received proper training of ACBT and FLUTTER.
0 kommentar(er)
